University of Michigan Health joins collaboration on improving heart failure outcomes

The University of Michigan Health is expanding efforts to improve care for patients with heart failure through a statewide initiative to identify and close gaps in treatment using data-driven decision making. Led by the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), the program will provide participating practices with performance benchmarks and feedback to support more consistent use of guideline-recommended therapies. The initiative will initially focus on patients with heart failure with reduced ejection fraction (HFrEF), a condition where proven treatments can significantly reduce hospitalizations and improve outcomes. Program leaders say that fewer than 1 in 6 eligible patients currently receive the full recommended medication regimen for HFrEF. 

“The launch of this program represents a resounding commitment to advancing best practices in heart failure care through cross-center, multidisciplinary collaboration,” said Jessica R. Golbus, M.D., director of BMC2 Heart Failure and a heart failure and transplant cardiologist at the University of Michigan Health. “By leveraging data, we can identify opportunities to extend the highest-quality care to a population of patients that is growing in our state.”

LEARN MORE